Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shahar Lavi

Showing results (121-130 of 143) with videos related to

Pageof 15
Sort By:
The Canadian Journal of Cardiology|January 16, 2026
Defining Metrics and the Framework for the Invasive Assessment of Patients with Presumed Coronary Microvascular and Vasomotor DysfunctionLaurie-Anne Boivin-Proulx, Erick Schampaert, Kevin Bainey, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|October 19, 2017
Duration of dual antiplatelet therapy and associated outcomes following percutaneous coronary intervention for acute myocardial infarction: contemporary practice insights from the Canadian Observational Antiplatelet StudyJuan J Russo, Shaun G Goodman, Akshay Bagai, et al.
The Canadian Journal of Cardiology|January 29, 2026
Defining Population at Risk and Assessment of Patients with Presumed Coronary Microvascular and Vasomotor DysfunctionLaurie-Anne Boivin-Proulx, Erick Schampaert, Kevin Bainey, et al.
American Heart Journal|March 1, 2014
Design and rationale of the TOTAL trial: a randomized trial of routine aspiration ThrOmbecTomy with percutaneous coronary intervention (PCI) versus PCI ALone in patients with ST-elevation myocardial infarction undergoing primary PCISanjit S Jolly, John Cairns, Salim Yusuf, et al.
American Heart Journal|September 24, 2016
Ischemic and bleeding events in patients with myocardial infarction undergoing percutaneous coronary intervention who require oral anticoagulation: Insights from the Canadian observational AntiPlatelet sTudySteven Sra, Mary K Tan, Shamir R Mehta, et al.
American Heart Journal|October 23, 2023
Effects of complete revascularization according to age in patients with ST-segment elevation myocardial infarction and multivessel disease (COMPLETE-AGE)Kevin R Bainey, David A Wood, Matthias Bossard, et al.
American Heart Journal|May 9, 2022
Morphine and clinical outcomes in patients with ST segment elevation myocardial infarction treated with fibrinolytic and antiplatelet therapy: Insights from the TREAT trialWarren J Cantor, Mary Tan, Otavio Berwanger, et al.
CJC Open|January 7, 2022
Provision of a DAPT Score to Cardiologists and Extension of Dual Antiplatelet Therapy Beyond 1 Year After ACS: Randomized Substudy of the Prospective Canadian ACS Reflective II StudyYaron Arbel, Ashish D Patel, Shaun G Goodman, et al.
Heart and Vessels|January 28, 2022
Use and outcomes of dual antiplatelet therapy for acute coronary syndrome in patients with chronic kidney disease: insights from the Canadian Observational Antiplatelet Study (COAPT)Carol Anne Graham, Mary K Tan, Derek P Chew, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 29, 2023
No-reflow after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: an angiographic core laboratory analysis of the TOTAL TrialMarc-André d'Entremont, Ashraf Alazzoni, Vladimir Dzavik, et al.
Pageof 15

Showing results (121-130 of 143) with videos related to

Sort By:
Pageof 15
The Canadian Journal of Cardiology|January 16, 2026
Defining Metrics and the Framework for the Invasive Assessment of Patients with Presumed Coronary Microvascular and Vasomotor DysfunctionLaurie-Anne Boivin-Proulx, Erick Schampaert, Kevin Bainey, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|October 19, 2017
Duration of dual antiplatelet therapy and associated outcomes following percutaneous coronary intervention for acute myocardial infarction: contemporary practice insights from the Canadian Observational Antiplatelet StudyJuan J Russo, Shaun G Goodman, Akshay Bagai, et al.
The Canadian Journal of Cardiology|January 29, 2026
Defining Population at Risk and Assessment of Patients with Presumed Coronary Microvascular and Vasomotor DysfunctionLaurie-Anne Boivin-Proulx, Erick Schampaert, Kevin Bainey, et al.
American Heart Journal|March 1, 2014
Design and rationale of the TOTAL trial: a randomized trial of routine aspiration ThrOmbecTomy with percutaneous coronary intervention (PCI) versus PCI ALone in patients with ST-elevation myocardial infarction undergoing primary PCISanjit S Jolly, John Cairns, Salim Yusuf, et al.
American Heart Journal|September 24, 2016
Ischemic and bleeding events in patients with myocardial infarction undergoing percutaneous coronary intervention who require oral anticoagulation: Insights from the Canadian observational AntiPlatelet sTudySteven Sra, Mary K Tan, Shamir R Mehta, et al.
American Heart Journal|October 23, 2023
Effects of complete revascularization according to age in patients with ST-segment elevation myocardial infarction and multivessel disease (COMPLETE-AGE)Kevin R Bainey, David A Wood, Matthias Bossard, et al.
American Heart Journal|May 9, 2022
Morphine and clinical outcomes in patients with ST segment elevation myocardial infarction treated with fibrinolytic and antiplatelet therapy: Insights from the TREAT trialWarren J Cantor, Mary Tan, Otavio Berwanger, et al.
CJC Open|January 7, 2022
Provision of a DAPT Score to Cardiologists and Extension of Dual Antiplatelet Therapy Beyond 1 Year After ACS: Randomized Substudy of the Prospective Canadian ACS Reflective II StudyYaron Arbel, Ashish D Patel, Shaun G Goodman, et al.
Heart and Vessels|January 28, 2022
Use and outcomes of dual antiplatelet therapy for acute coronary syndrome in patients with chronic kidney disease: insights from the Canadian Observational Antiplatelet Study (COAPT)Carol Anne Graham, Mary K Tan, Derek P Chew, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 29, 2023
No-reflow after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: an angiographic core laboratory analysis of the TOTAL TrialMarc-André d'Entremont, Ashraf Alazzoni, Vladimir Dzavik, et al.
Pageof 15